Observational studyEuropean geriatric medicine2025
Validation of the Frail-VIG frailty index in geriatric population with femur fracture.
Observational study in European geriatric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOur aim is to analyse whether the Frail-VIG index (frailty index validated in the geriatric population) maintains its predictive capacity for mortality in geriatric patients with femur fracture (FF).
methodsObservational prospective cohort study including patients over 65 years of age consecutively admitted for FF to a community hospital. Patients were classified according to their frailty degree into three groups: none/initial frailty (Frail-VIG index < 0.36), moderate frailty (Frail-VIG index: 0.36-0.50), and advanced frailty (Frail-VIG index > 0.50). The association between 12-month mortality and frailty was estimated in an adjusted Cox regression model and expressed as hazard ratio (HR) with 95% confidence interval (95% CI). ROC curves were analysed to assess the prognostic capacity of Frail-VIG index. The reliability and feasibility were also assessed.
results150 patients were included (78% women and mean age 88 years). Patients with advanced frailty had more geriatric syndromes and comorbidities and worse cognitive, emotional, and functional status. In-hospital and 30-day mortality were similar between the three groups. After 12 months of follow-up, all-cause mortality was higher in patients with moderate and advanced frailty with an adjusted HR (95% CI) of 3.1 (1.33-7.43; p = 0.009) and 3.93 (1.52-10.1; p = 0.005), respectively. The under the ROC curve area at 12 months was 0.71 (0.62-0.80). The intraclass correlation coefficient for reliability was 0.891 (0.804-0.891) and the feasibility showed a mean (SD) of 4.83 (1.39) min.
conclusionThe Frail-VIG index has a good predictive capacity for 12-month mortality in geriatric population with FF and also shows very good reliability and feasibility.
Indexed as
Identifiers
40009281What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.